MARKET

UNCY

UNCY

Unicycive Therapeutics Inc
NASDAQ
0.5741
-0.0109
-1.86%
Opening 13:16 03/17 EDT
OPEN
0.5899
PREV CLOSE
0.5850
HIGH
0.5990
LOW
0.5701
VOLUME
170.76K
TURNOVER
--
52 WEEK HIGH
1.730
52 WEEK LOW
0.2020
MARKET CAP
62.24M
P/E (TTM)
-2.9396
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at UNCY last week (0310-0314)?
Weekly Report · 10h ago
UNICYCIVE TO HIGHLIGHT PATIENT REPORTED OUTCOMES DATA AT UPCOMING MEDICAL MEETINGS SHOWING OXYLANTHANUM CARBONATE REDUCED PILL BURDEN AND IMPROVED ADHERENCE IN TREATMENT OF HYPERPHOSPHATEMIA
Reuters · 4d ago
Weekly Report: what happened at UNCY last week (0303-0307)?
Weekly Report · 03/10 11:54
Weekly Report: what happened at UNCY last week (0224-0228)?
Weekly Report · 03/03 11:53
Weekly Report: what happened at UNCY last week (0217-0221)?
Weekly Report · 02/24 11:53
Noble Financial Sticks to Its Buy Rating for Unicycive Therapeutics (UNCY)
TipRanks · 02/21 14:55
Unicycive Therapeutics Reports Publication Of Preclinical Data In American Society Of Nephrology Journal, Kidney360
Benzinga · 02/20 12:33
Unicycive Therapeutics’ OLC shows synergy with tenapanor in published study
TipRanks · 02/20 12:20
More
About UNCY
Unicycive Therapeutics, Inc. is a biotechnology company that is developing treatments for certain medical conditions. Its programs are focused on kidney disease, an area that has the potential to offer medical benefits. Its development programs are focused on two novel therapies: Oxylanthanum Carbonate, and UNI 494. Oxylanthanum Carbonate is a novel investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. UNI-494 is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury. Oxylanthanum Carbonate and UNI 494 were initially developed by and licensed to it from Spectrum Pharmaceuticals (Spectrum) and Sphaera Pharma, respectively.

Webull offers Unicycive Therapeutics Inc stock information, including NASDAQ: UNCY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UNCY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UNCY stock methods without spending real money on the virtual paper trading platform.